(Abstracted from JAMA 2019;321(18):1811–1819)
Preexisting diabetes complicates 0.9% of pregnancies in the US and increases the risk of adverse maternal and neonatal outcomes, specifically linked to preeclampsia, congenital anomalies, preterm delivery, and stillbirth. With type 1 and type 2 diabetes becoming more common, clinicians need to review planning and optimization of glycemic control with patients before pregnancy to mitigate the risk associated with diabetes.
Duke University Medical Center, Durham, NC (A.-S.A.); Brigham and Women's Hospital, Boston, MA (R.B.); and Keck School of Medicine of the University of Southern California, Los Angeles, CA (A.L.P.)